Effect of physician-pharmacist information sharing on blood pressure
Not Applicable
Recruiting
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000049645
- Lead Sponsor
- Kanagawa Physicians Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with an office systolic blood pressure >179mmHg and/or diastolic BP >109mmHg.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie blood pressure regulation in hypertension when physician-pharmacist collaboration is optimized?
How does active two-way communication between physicians and pharmacists compare to standard-of-care approaches in hypertension management?
Are there specific biomarkers that correlate with improved blood pressure outcomes in physician-pharmacist collaborative care models?
What adverse events are associated with physician-pharmacist shared decision-making in antihypertensive therapy?
What combination strategies or drug classes are being evaluated alongside physician-pharmacist information sharing in JPRN-UMIN000049645 for hypertension treatment?